Suppr超能文献

[抗人CD25分子单链抗体可变区(scFv)的构建、表达及鉴定]

[Construction, expression and identification of a single chain antibody variable (scFv) against human CD25 molecule].

作者信息

Shen Tao, Zhang Ai-Hua, Bi Lan, Shi Liang-Ru

机构信息

Department of Microbiology and Immunology, Wenzhou Medical College, Wenzhou, China.

出版信息

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Mar;23(3):264-6.

Abstract

AIM

To construct and express a single chain fragment variable (scFv) fragment against human CD25 molecule and identify its bioactivity.

METHODS

V(H) and V(L) genes of anti-murine CD25 monoclonal antibody were cloned by RT-PCR from hybridoma cell WuTac secreting anti-CD25 mAb. scFv gene was spliced by sequence overlap extending (SOE) PCR, and then it was ligated into pMD18T vector to be identified by endonuclease digestion, PCR and sequencing. scFv gene was cloned into pBAD/gIIIA expression vector and transformed into TOP10 E.coli. After positive clones were induced by L-arabinose for 4 hours, the purity of protein was detected by SDS-PAGE and its bioactivity was identified by competitive inhibition ELISA test.

RESULTS

scFv genes of V(L)-(GGGGSGGGGSSGGGS)-V(H) was constructed successfully. The V(H) chain consisted of 351 bp and encoded 117 amino acids, which belonged to heavy chain subgroup III (C) of mouse immunoglobulin variable region. The V(L) chain consisted of 318 bp and encoded 106 amino acids, which belonged to light chain subgroup IV of mouse immunoglobulin variable region. The scFv antibody expressed by TOP10 fused with 6xHis and C-myc tag protein and the relative molecular mass of fusion protein was about 31,000. Competitive inhibition ELISA test indicated the scFv antibody had specific activity.

CONCLUSION

The expressed product of the single-chain antibody shows some specific binding capacity, which provides a basis for the clinical application of anti-CD25 single-chain antibody.

摘要

目的

构建并表达抗人CD25分子的单链抗体可变区(scFv)片段,并鉴定其生物活性。

方法

从分泌抗CD25单克隆抗体的杂交瘤细胞WuTac中,通过RT-PCR克隆抗鼠CD25单克隆抗体的V(H)和V(L)基因。采用序列重叠延伸(SOE)PCR拼接scFv基因,然后将其连接到pMD18T载体中,通过内切酶消化、PCR及测序进行鉴定。将scFv基因克隆到pBAD/gIIIA表达载体中,并转化到TOP10大肠杆菌中。用L-阿拉伯糖诱导阳性克隆4小时后,通过SDS-PAGE检测蛋白纯度,并用竞争性抑制ELISA试验鉴定其生物活性。

结果

成功构建了V(L)-(GGGGSGGGGSSGGGS)-V(H)的scFv基因。V(H)链由351 bp组成,编码117个氨基酸,属于小鼠免疫球蛋白可变区重链亚组III(C)。V(L)链由318 bp组成,编码106个氨基酸,属于小鼠免疫球蛋白可变区轻链亚组IV。TOP10表达的scFv抗体与6xHis和C-myc标签蛋白融合,融合蛋白的相对分子质量约为31000。竞争性抑制ELISA试验表明该scFv抗体具有特异性活性。

结论

单链抗体的表达产物具有一定的特异性结合能力,为抗CD25单链抗体的临床应用提供了依据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验